INS and hyperprolactinemia: Oral medications, such as Bromocript 2.5 mg quaque die (Qd) for hyperprolactinemia, Euthyrox (Merck) 112.5 μg (Qd) for hypothyroidism, metformin 0.5 g bis in die (Bid) for insulin resistance, were used long-term under MDT monitoring.